---
title: "Tamibarotene - Acute Promyelocytic Leukemia, Fab M3"
sidebar: mydoc_sidebar
permalink: db04942-mesh-d015473-1.html
toc: false 
---


Path ID: `DB04942_MESH_D015473_1`
{% include image.html url="images/db04942-mesh-d015473-1.png" file="db04942-mesh-d015473-1.png" alt="db04942-mesh-d015473-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C061133 | tamibarotene | Drug |
| UniProt:P10826 | Retinoic acid receptor beta | Protein |
| UniProt:P10276 | Retinoic acid receptor alpha | Protein |
| GO:0008283 | cell population proliferation | BiologicalProcess |
| MESH:D015473 | Acute promyelocytic leukemia, FAB M3 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tamibarotene | POSITIVELY REGULATES | Retinoic Acid Receptor Beta |
| Tamibarotene | POSITIVELY REGULATES | Retinoic Acid Receptor Alpha |
| Retinoic Acid Receptor Beta | NEGATIVELY REGULATES | Cell Population Proliferation |
| Retinoic Acid Receptor Alpha | NEGATIVELY REGULATES | Cell Population Proliferation |
| Cell Population Proliferation | POSITIVELY CORRELATED WITH | Acute Promyelocytic Leukemia, Fab M3 |
|---------|-----------|---------|

Comment: The drug has been approved in Japan but not yet in the US

Reference: 
  - [https://go.drugbank.com/drugs/DB04942](https://go.drugbank.com/drugs/DB04942)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL25202/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL25202/)
  - [https://en.wikipedia.org/wiki/Tamibarotene](https://en.wikipedia.org/wiki/Tamibarotene)
